Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain langauage summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Pooled analysis of 24-h lung function following treatment with the LAMA/LABA glycopyrronium/formoterol fumarate fixed-dose combination, delivered by a novel MDI co-suspension technology (GFF MDI), in COPD patients (pts), European Respiratory Journal, September 2016, European Respiratory Society (ERS), DOI: 10.1183/13993003.congress-2016.pa994.
You can read the full text:

Read

Contributors

Be the first to contribute to this page